Amylyx Pharmaceuticals Inc (AMLX)
2.005
+0.08
(+3.89%)
USD |
NASDAQ |
May 02, 16:00
2.005
0.00 (0.00%)
After-Hours: 17:21
Amylyx Pharmaceuticals Total Assets (Quarterly): 517.45M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 517.45M |
September 30, 2023 | 466.58M |
June 30, 2023 | 453.59M |
March 31, 2023 | 407.96M |
December 31, 2022 | 391.45M |
September 30, 2022 | 181.44M |
Date | Value |
---|---|
June 30, 2022 | 225.24M |
March 31, 2022 | 274.44M |
December 31, 2021 | 105.61M |
September 30, 2021 | 130.46M |
December 31, 2020 | 14.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.10M
Minimum
Dec 2020
517.45M
Maximum
Dec 2023
288.03M
Average
274.44M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
Cassava Sciences Inc | 151.66M |
iRhythm Technologies Inc | 433.14M |
Bristol-Myers Squibb Co | 99.03B |
Moderna Inc | 18.43B |
ACADIA Pharmaceuticals Inc | 748.96M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 84.02M |
Shareholders Equity (Quarterly) | 433.43M |
Current Ratio | 5.664 |